Technical Articles
Tumor immune evasion
DcR3: From Driver of Tumor Immune Evasion to Inflammation Brake—Translational Prospects of a Two-Faced Target
2026-09-20DcR3 promotes immune escape in the tumor microenvironment while acting as inhibitory feedback in chronic inflammation. This article reviews its bidirectional mechanisms, sources of expression regulation, variable-control essentials on both research f
View details
- Immunity/Inflamma
- DcR3
- Tumor immune evasion
- Chronic inflammation
- Immunosuppression
- Biomarker
- UA019076
The Immune System's Decoy Keys: How DcR3 Intercepts Three Death Signals
2026-09-20As a soluble decoy receptor, DcR3 intercepts FasL, LIGHT and TL1A one after another. Following the process of ligand departure, key swap and signal shutdown, this article dissects the decoy mechanism and the logic of its experimental validation.
View details
- Immunity/Inflamma
- DcR3
- Decoy receptor
- FasL
- LIGHT
- TL1A
- Tumor immune evasion
- UA019076
- 1
Link：
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy 
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
Business license (three certificates in one) Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.
